SE0102921D0 - Pharmaceutically useful compounds - Google Patents

Pharmaceutically useful compounds

Info

Publication number
SE0102921D0
SE0102921D0 SE0102921A SE0102921A SE0102921D0 SE 0102921 D0 SE0102921 D0 SE 0102921D0 SE 0102921 A SE0102921 A SE 0102921A SE 0102921 A SE0102921 A SE 0102921A SE 0102921 D0 SE0102921 D0 SE 0102921D0
Authority
SE
Sweden
Prior art keywords
pharmaceutically useful
useful compounds
thrombin
useful
compound
Prior art date
Application number
SE0102921A
Other languages
English (en)
Swedish (sv)
Inventor
Tord Inghardt
Anders M Johansson
Arne Svensson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0102921A priority Critical patent/SE0102921D0/xx
Publication of SE0102921D0 publication Critical patent/SE0102921D0/xx
Priority to ARP010105543A priority patent/AR035216A1/es
Priority to MYPI20015470A priority patent/MY136133A/en
Priority to IL15609601A priority patent/IL156096A0/xx
Priority to KR1020087014404A priority patent/KR100914537B1/ko
Priority to JP2002546515A priority patent/JP4177101B2/ja
Priority to KR1020087014402A priority patent/KR100914535B1/ko
Priority to KR1020037007353A priority patent/KR100914016B1/ko
Priority to ES01998535T priority patent/ES2341318T3/es
Priority to DK01998535.7T priority patent/DK1347955T3/da
Priority to UA2003054395A priority patent/UA78195C2/uk
Priority to CNB018223168A priority patent/CN1291975C/zh
Priority to SI200130965T priority patent/SI1347955T1/sl
Priority to CA2436220A priority patent/CA2436220C/fr
Priority to PL362917A priority patent/PL207045B1/pl
Priority to MXPA03004794A priority patent/MXPA03004794A/es
Priority to SK651-2003A priority patent/SK287692B6/sk
Priority to AU2002218618A priority patent/AU2002218618B2/en
Priority to CZ20031514A priority patent/CZ303708B6/cs
Priority to BR0115861-9A priority patent/BR0115861A/pt
Priority to DE60141603T priority patent/DE60141603D1/de
Priority to NZ526205A priority patent/NZ526205A/en
Priority to KR1020097002806A priority patent/KR100947296B1/ko
Priority to PCT/SE2001/002657 priority patent/WO2002044145A1/fr
Priority to EEP200300259A priority patent/EE05382B1/xx
Priority to HK04100090.5A priority patent/HK1057214B/en
Priority to PT01998535T priority patent/PT1347955E/pt
Priority to AT01998535T priority patent/ATE461171T1/de
Priority to EP01998535A priority patent/EP1347955B1/fr
Priority to HU0302487A priority patent/HU228814B1/hu
Priority to RU2003115420/04A priority patent/RU2300521C2/ru
Priority to EP10152378A priority patent/EP2186800A1/fr
Priority to UY27425A priority patent/UY27425A1/es
Priority to MYPI20023196A priority patent/MY132033A/en
Priority to NZ531109A priority patent/NZ531109A/xx
Priority to KR1020047002939A priority patent/KR100928285B1/ko
Priority to CNB028169247A priority patent/CN1301969C/zh
Priority to IL16006802A priority patent/IL160068A0/xx
Priority to EP02759050A priority patent/EP1423362B1/fr
Priority to AT02759050T priority patent/ATE435201T1/de
Priority to MXPA04001825A priority patent/MXPA04001825A/es
Priority to UA2004020839A priority patent/UA75937C2/uk
Priority to ES02759050T priority patent/ES2326963T3/es
Priority to JP2003523215A priority patent/JP4386724B2/ja
Priority to HK04106327.7A priority patent/HK1063627B/en
Priority to PCT/SE2002/001557 priority patent/WO2003018551A1/fr
Priority to DE60232802T priority patent/DE60232802D1/de
Priority to BR0211847-5A priority patent/BR0211847A/pt
Priority to RU2004103625/04A priority patent/RU2341516C2/ru
Priority to HU0401189A priority patent/HUP0401189A2/hu
Priority to US10/487,805 priority patent/US7056907B2/en
Priority to ARP020103296A priority patent/AR037498A1/es
Priority to AU2002324410A priority patent/AU2002324410B2/en
Priority to CA2456426A priority patent/CA2456426C/fr
Priority to PL02369325A priority patent/PL369325A1/xx
Priority to SA02230278A priority patent/SA02230278B1/ar
Priority to BG107825A priority patent/BG66261B1/bg
Priority to IS6828A priority patent/IS2755B/is
Priority to NO20032465A priority patent/NO325228B1/no
Priority to ZA200401083A priority patent/ZA200401083B/en
Priority to NO20040813A priority patent/NO326496B1/no
Priority to IS7162A priority patent/IS7162A/is
Priority to US11/520,052 priority patent/US20070218136A1/en
Priority to US11/520,063 priority patent/US7803954B2/en
Priority to US11/797,656 priority patent/US7645751B2/en
Priority to AU2007203509A priority patent/AU2007203509A1/en
Priority to AU2007203520A priority patent/AU2007203520B2/en
Priority to NO20080031A priority patent/NO20080031L/no
Priority to NO20080030A priority patent/NO20080030L/no
Priority to JP2008006611A priority patent/JP2008138009A/ja
Priority to JP2008006608A priority patent/JP2008156362A/ja
Priority to US12/491,456 priority patent/US20100087651A1/en
Priority to ARP090102945A priority patent/AR072331A2/es
Priority to CY20101100436T priority patent/CY1113487T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/516—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0102921A 2000-12-01 2001-08-30 Pharmaceutically useful compounds SE0102921D0 (sv)

Priority Applications (74)

Application Number Priority Date Filing Date Title
SE0102921A SE0102921D0 (sv) 2001-08-30 2001-08-30 Pharmaceutically useful compounds
ARP010105543A AR035216A1 (es) 2000-12-01 2001-11-28 Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
MYPI20015470A MY136133A (en) 2000-12-01 2001-11-29 New mandelic acid derivatives and their use as thrombin inhibitors
IL15609601A IL156096A0 (en) 2000-12-01 2001-11-30 New mandelic acid derivatives and their use as thrombin inhibitors
KR1020087014404A KR100914537B1 (ko) 2000-12-01 2001-11-30 신규한 만델산 유도체 및 트롬빈 억제제로서 이들의 용도
JP2002546515A JP4177101B2 (ja) 2000-12-01 2001-11-30 新規マンデル酸誘導体とそれらのトロンビン阻害剤としての使用
KR1020087014402A KR100914535B1 (ko) 2000-12-01 2001-11-30 신규한 만델산 유도체 및 트롬빈 억제제로서 이들의 용도
KR1020037007353A KR100914016B1 (ko) 2000-12-01 2001-11-30 신규한 만델산 유도체 및 트롬빈 억제제로서 이들의 용도
ES01998535T ES2341318T3 (es) 2000-12-01 2001-11-30 Nuevos derivados del acido mandelico y su uso como inhibidores de trombina.
DK01998535.7T DK1347955T3 (da) 2000-12-01 2001-11-30 Nye mandelsyrederivater og deres anvendelse som throbin-hæmmere
UA2003054395A UA78195C2 (uk) 2001-08-30 2001-11-30 Похідні мигдалевої кислоти та їх застосування як інгібіторів тромбіну, фармацевтична композиція на їх основі
CNB018223168A CN1291975C (zh) 2000-12-01 2001-11-30 新型扁桃酸衍生物及其作为凝血酶抑制剂的用途
SI200130965T SI1347955T1 (sl) 2000-12-01 2001-11-30 Novi derivati mandljeve kisline in njihova uporaba kot trombinski inhibitorji
CA2436220A CA2436220C (fr) 2000-12-01 2001-11-30 Nouveaux derives d'acide mandelique et leur utilisation comme inhibiteurs de thrombine
PL362917A PL207045B1 (pl) 2000-12-01 2001-11-30 Pochodne kwasu migdałowego oraz ich kompozycje farmaceutyczne
MXPA03004794A MXPA03004794A (es) 2000-12-01 2001-11-30 Derivados de acido mandelico y su uso como inhibidores de trombina.
SK651-2003A SK287692B6 (sk) 2000-12-01 2001-11-30 Deriváty kyseliny mandľovej a ich použitie ako inhibítorov trombínu
AU2002218618A AU2002218618B2 (en) 2000-12-01 2001-11-30 New mandelic acid derivatives and their use as throbin inhibitors
CZ20031514A CZ303708B6 (cs) 2000-12-01 2001-11-30 Nové deriváty kyseliny mandlové a jejich pouzití jako inhibitory trombinu
BR0115861-9A BR0115861A (pt) 2000-12-01 2001-11-30 Composto, derivado farmaceuticamente aceitável de um composto, formulação farmacêutica, uso de um composto, métodos de tratamento de uma condição onde a inibição da trombina é requerida e de uma condição onde a terapia anticoagulante é indicada, e, processo para a preparação de um composto
DE60141603T DE60141603D1 (de) 2000-12-01 2001-11-30 Neue mandelsäurederivate und deren verwendung als thrombininhibitoren
NZ526205A NZ526205A (en) 2000-12-01 2001-11-30 New mandelic acid derivatives and their use as thrombin inhibitors
KR1020097002806A KR100947296B1 (ko) 2000-12-01 2001-11-30 신규한 만델산 유도체 및 트롬빈 억제제로서 이들의 용도
PCT/SE2001/002657 WO2002044145A1 (fr) 2000-12-01 2001-11-30 Nouveaux derives d'acide mandelique et leur utilisation comme inhibiteurs de thrombine
EEP200300259A EE05382B1 (et) 2000-12-01 2001-11-30 MandelhappeÁderivaadid,ÁnendeÁvalmistamiseÁmeetod,ÁnendeÁkasutamineÁtrombiiniÁinhibiitoritenaÁjaÁneidÁsisaldavadÁravimkoostised
HK04100090.5A HK1057214B (en) 2000-12-01 2001-11-30 New mandelic acid derivatives and their use as throbin inhibitors
PT01998535T PT1347955E (pt) 2000-12-01 2001-11-30 Novos derivados de ácido mandélico e sua utilização como inibidores de trombina
AT01998535T ATE461171T1 (de) 2000-12-01 2001-11-30 Neue mandelsäurederivate und deren verwendung als thrombininhibitoren
EP01998535A EP1347955B1 (fr) 2000-12-01 2001-11-30 Nouveaux derives d'acide mandelique et leur utilisation comme inhibiteurs de thrombine
HU0302487A HU228814B1 (hu) 2000-12-01 2001-11-30 Trombin inhibitor hatású mandulasav-származékok és az ezeket tartalmazó gyógyszerkészítmények
RU2003115420/04A RU2300521C2 (ru) 2000-12-01 2001-11-30 Новые производные миндальной кислоты и их применение в качестве ингибиторов тромбина
EP10152378A EP2186800A1 (fr) 2000-12-01 2001-11-30 Nouveaux dérivés d'acide mandélique et leur utilisant en tant qu'inhibiteurs de thrombine
UY27425A UY27425A1 (es) 2001-08-30 2002-08-28 Nuevos derivados de ácido mandelicoy su uso como inhibidores de trombina
MYPI20023196A MY132033A (en) 2001-08-30 2002-08-28 New mandelic acid derivatives and their use as thrombin inhibitors
NZ531109A NZ531109A (en) 2001-08-30 2002-08-30 New mandelic acid derivatives and their use as thrombin inhibitors
KR1020047002939A KR100928285B1 (ko) 2001-08-30 2002-08-30 신규한 만델산 유도체 및 이것의 트롬빈 억제제로서의 용도
CNB028169247A CN1301969C (zh) 2001-08-30 2002-08-30 新的扁桃酸衍生物及其作为凝血酶抑制剂的应用
IL16006802A IL160068A0 (en) 2001-08-30 2002-08-30 Mew mandelic acid derivatives and their use as thrombin inhibitors
EP02759050A EP1423362B1 (fr) 2001-08-30 2002-08-30 Nouveau derive d'acide mandelique et son utilisation comme inhibiteur de la thrombine
AT02759050T ATE435201T1 (de) 2001-08-30 2002-08-30 Neues mandelsäurederivat und seine verwendung als thrombininhibitor
MXPA04001825A MXPA04001825A (es) 2001-08-30 2002-08-30 Derivados de acido mandelico nuevos y su uso como inhibidores de trombina.
UA2004020839A UA75937C2 (en) 2001-08-30 2002-08-30 Amygdalic acid derivatives and use thereof as a thrombin inhibitors
ES02759050T ES2326963T3 (es) 2001-08-30 2002-08-30 Nuevo derivado del acido mandelico y su uso como inhibidor de la trombina.
JP2003523215A JP4386724B2 (ja) 2001-08-30 2002-08-30 新規マンデル酸誘導体とトロンビン阻害剤としてのその使用
HK04106327.7A HK1063627B (en) 2001-08-30 2002-08-30 New mandelic acid derivative and its use as thrombin inhibitor
PCT/SE2002/001557 WO2003018551A1 (fr) 2001-08-30 2002-08-30 Nouveaux derives d'acide mandelique et leur utilisation comme inhibiteurs de la thrombine
DE60232802T DE60232802D1 (de) 2001-08-30 2002-08-30 Neues mandelsäurederivat und seine verwendung als thrombininhibitor
BR0211847-5A BR0211847A (pt) 2001-08-30 2002-08-30 Composto ou um derivado farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso do composto ou do derivado, métodos para tratar uma condição onde a inibição de trombina é requerida, e para tratar uma condição onde a terapia anticoagulante é indicada, e, processo para a preparação de um composto
RU2004103625/04A RU2341516C2 (ru) 2001-08-30 2002-08-30 Новые производные миндальной кислоты и их применение в качестве ингибиторов тромбина
HU0401189A HUP0401189A2 (hu) 2001-08-30 2002-08-30 Új mandulasavszármazékok és felhasználásuk trombin inhibitorokként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
US10/487,805 US7056907B2 (en) 2001-08-30 2002-08-30 Mandelic acid derivatives and their use as thrombin inhibitors
ARP020103296A AR037498A1 (es) 2001-08-30 2002-08-30 Compuesto n-(4-amidino-2,6-difluorobenzil)-1-(2-(3-cloro-5-(difluorometoxi)fenil)-2-hidroxiacetil)azetidina-2-carboxamida y compuesto derivado del mismo, composicion farmaceutica, su uso en la preparacion de un medicamento y rutas sinteticas para su produccion
AU2002324410A AU2002324410B2 (en) 2001-08-30 2002-08-30 New mandelic acid derivatives and their use as thrombin inhibitors
CA2456426A CA2456426C (fr) 2001-08-30 2002-08-30 Nouveaux derives d'acide mandelique et leur utilisation comme inhibiteurs de la thrombine
PL02369325A PL369325A1 (pl) 2001-08-30 2002-08-30 Nowe pochodne kwasu migdałowego i ich zastosowanie jako inhibitorów trombiny
SA02230278A SA02230278B1 (ar) 2001-08-30 2002-08-31 مشتقات جديدة لحامض الماندليك واستخداماتها كمثبطات للثرومبين
BG107825A BG66261B1 (bg) 2000-12-01 2003-05-19 Производни на бадемовата киселина и тяхното използване като инхибитори на тромбин
IS6828A IS2755B (is) 2000-12-01 2003-05-27 Aðferð til að vinna kjötmjöl og feiti úr hráefnum af dýrum
NO20032465A NO325228B1 (no) 2000-12-01 2003-05-30 Nye mandelsyre-derivater og anvendelse derav samt farmasoytisk formulering
ZA200401083A ZA200401083B (en) 2001-08-30 2004-02-10 New mandelic and derivatives and their use as thrombin inhibitors.
NO20040813A NO326496B1 (no) 2001-08-30 2004-02-24 Nye mandelsyre-derivater, farmasoytiske formuleringer inneholdende slike samt anvendelse derav for fremstilling av medikament for behandling av sykdom
IS7162A IS7162A (is) 2001-08-30 2004-02-26 Nýjar möndlusýruafleiður og notkun þeirra sem þrombínhemla
US11/520,052 US20070218136A1 (en) 2000-12-01 2006-09-13 New mandelic acid derivatives and their use as thrombin inhibitors
US11/520,063 US7803954B2 (en) 2000-12-01 2006-09-13 Mandelic acid derivatives and their use as thrombin inhibitors
US11/797,656 US7645751B2 (en) 2000-12-01 2007-05-04 Mandelic acid derivatives and their use as thrombin inhibitors
AU2007203509A AU2007203509A1 (en) 2000-12-01 2007-07-27 New mandelic acid derivatives and their use as throbin inhibitors
AU2007203520A AU2007203520B2 (en) 2000-12-01 2007-07-27 New mandelic acid derivatives and their use as throbin inhibitors
NO20080031A NO20080031L (no) 2000-12-01 2008-01-03 Nye mandelsyre-derivater og anvendelse derav som trombininhibitorer
NO20080030A NO20080030L (no) 2000-12-01 2008-01-03 Nye mandelsyre-derivater og anvendelse derav som trombininhibitorer
JP2008006611A JP2008138009A (ja) 2000-12-01 2008-01-16 新規マンデル酸誘導体とそれらのトロンビン阻害剤としての使用
JP2008006608A JP2008156362A (ja) 2000-12-01 2008-01-16 新規マンデル酸誘導体とそれらのトロンビン阻害剤としての使用
US12/491,456 US20100087651A1 (en) 2000-12-01 2009-06-25 New mandelic acid derivatives and their use as thrombin inhibitors
ARP090102945A AR072331A2 (es) 2000-12-01 2009-07-31 Derivados de acido mandelico, formulacion farmaceutica, procesos para la preparacion de estos derivados, y compuestos intermediarios
CY20101100436T CY1113487T1 (el) 2000-12-01 2010-05-17 Νεα παραγωγα μανδελικου οξεος και η χρηση τους ως αναστολεις θροβινης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102921A SE0102921D0 (sv) 2001-08-30 2001-08-30 Pharmaceutically useful compounds

Publications (1)

Publication Number Publication Date
SE0102921D0 true SE0102921D0 (sv) 2001-08-30

Family

ID=20285211

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102921A SE0102921D0 (sv) 2000-12-01 2001-08-30 Pharmaceutically useful compounds

Country Status (9)

Country Link
US (1) US7056907B2 (fr)
KR (1) KR100928285B1 (fr)
AR (1) AR037498A1 (fr)
CA (1) CA2456426C (fr)
MY (1) MY132033A (fr)
SA (1) SA02230278B1 (fr)
SE (1) SE0102921D0 (fr)
UA (1) UA75937C2 (fr)
ZA (1) ZA200401083B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR034517A1 (es) 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663374A (en) * 1970-08-14 1972-05-16 Geomet Method and apparatus for quantitating enzyme activity
US4014653A (en) * 1974-12-26 1977-03-29 Denver Chemical Manufacturing Company Micro-filter
US4170056A (en) * 1976-03-25 1979-10-09 Baxter Travenol Laboratories, Inc. Blood filter
US4167875A (en) * 1976-08-05 1979-09-18 Meakin John C Filtration method and apparatus
DE7636679U1 (de) * 1976-11-22 1977-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Vorrichtung zur chemischen und/oder physikalischen behandlung von fluessigkeiten
US4127131A (en) * 1977-06-20 1978-11-28 Johnson & Johnson Hub assembly for use in the filtration of fluids and method of making the same
US4301010A (en) * 1980-03-10 1981-11-17 Spectrum Medical Industries, Inc. Vacuum filter
IL60645A (en) * 1980-07-21 1984-02-29 Cais Michael Method and device for mass transfer and separation through selective barriers
US4472276A (en) * 1980-07-24 1984-09-18 The Regents Of The University Of California High-speed centrifugal filter assembly and method
GB8311730D0 (en) * 1983-04-29 1983-06-02 Bagshawe K D Handling of reaction mixtures
US4623461A (en) * 1985-05-31 1986-11-18 Murex Corporation Transverse flow diagnostic device
DE3520489C1 (de) * 1985-06-07 1986-05-22 B. Braun Melsungen Ag, 3508 Melsungen Probeentnahmegeraet
US5047215A (en) * 1985-06-18 1991-09-10 Polyfiltronics, Inc. Multiwell test plate
US4948442A (en) * 1985-06-18 1990-08-14 Polyfiltronics, Inc. Method of making a multiwell test plate
FR2584498B1 (fr) * 1985-07-02 1987-10-16 Centre Nat Rech Scient Dispositif pour detecter sur une feuille de nitrocellulose la presence de complexes macromoleculaires, tels que antigenes/anticorps et procede de mise en oeuvre.
US5120504A (en) * 1986-07-14 1992-06-09 Hybritech Incorporated Apparatus for immunoassays with vent chennels in the container side wall
US4895706A (en) * 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US4948564A (en) * 1986-10-28 1990-08-14 Costar Corporation Multi-well filter strip and composite assemblies
US4797259A (en) * 1986-12-15 1989-01-10 Pall Corporation Well-type diagnostic plate device
US4787988A (en) * 1987-02-20 1988-11-29 Biomedical Research And Development Laboratories, Inc. Cell harvester
US4800020A (en) * 1987-05-21 1989-01-24 Xydex Corporation Piston filtering device
AU2303588A (en) * 1987-08-27 1989-03-31 Polyfiltronics Limited Filter units for biological sample preparation
US4902481A (en) * 1987-12-11 1990-02-20 Millipore Corporation Multi-well filtration test apparatus
DE3804429A1 (de) * 1988-02-12 1989-08-24 Schleicher & Schuell Gmbh Einmalfilter
US5202267A (en) * 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5423989A (en) * 1988-05-19 1995-06-13 Chemtrack, Inc. Plasma forming device
US5108704A (en) * 1988-09-16 1992-04-28 W. R. Grace & Co.-Conn. Microfiltration apparatus with radially spaced nozzles
US4948561A (en) * 1989-02-09 1990-08-14 Eastman Kodak Company Multiple level filter device and kit containing same
ATE117804T1 (de) * 1989-06-05 1995-02-15 Janssen Pharmaceutica Nv Festphasen-test zur verwendung mit einem physikalischen entwickler.
US5124041A (en) * 1989-07-28 1992-06-23 Applied Biosystems, Inc. Biomolecule sample immobilization
US5846745A (en) * 1990-07-20 1998-12-08 Camas Diagnostic Company Method and apparatus for the on-location field detection of unidentified antigenic substances
US5334538A (en) * 1990-11-26 1994-08-02 V-Tech, Inc. Gold sol immunoassay system and device
US5264184A (en) * 1991-03-19 1993-11-23 Minnesota Mining And Manufacturing Company Device and a method for separating liquid samples
US5116496A (en) * 1991-03-19 1992-05-26 Minnesota Mining And Manufacturing Company Membrane-containing wells for microtitration and microfiltration
US5342581A (en) * 1993-04-19 1994-08-30 Sanadi Ashok R Apparatus for preventing cross-contamination of multi-well test plates
SA96170106A (ar) 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
US5679310A (en) * 1995-07-11 1997-10-21 Polyfiltronics, Inc. High surface area multiwell test plate
US5800784A (en) * 1996-07-09 1998-09-01 Horn; Marcus J. Chemical sample treatment system and cassette, and methods for effecting multistep treatment process
US6159368A (en) * 1998-10-29 2000-12-12 The Perkin-Elmer Corporation Multi-well microfiltration apparatus
KR100639274B1 (ko) * 1999-01-13 2006-10-27 아스트라제네카 아베 신규 아미디노벤질아민 유도체 및 트롬빈 억제제로서의 용도
DK1311480T3 (da) 2000-08-16 2008-12-01 Astrazeneca Ab Nye amidinoderivater og deres anvendelse som thrambininhibitor
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors

Also Published As

Publication number Publication date
CA2456426A1 (fr) 2003-03-06
ZA200401083B (en) 2005-05-10
CA2456426C (fr) 2011-01-11
AR037498A1 (es) 2004-11-17
KR100928285B1 (ko) 2009-11-25
KR20040029091A (ko) 2004-04-03
US20040242492A1 (en) 2004-12-02
US7056907B2 (en) 2006-06-06
HK1063627A1 (en) 2005-01-07
UA75937C2 (en) 2006-06-15
SA02230278B1 (ar) 2008-11-18
MY132033A (en) 2007-09-28

Similar Documents

Publication Publication Date Title
MY136133A (en) New mandelic acid derivatives and their use as thrombin inhibitors
GEP20074098B (en) Lactam-containing compounds and derivatives thereof as factor xa inhibitors
MX9804623A (es) Precursores inactivos de farmacos inhibidores de trombina.
CY1110527T1 (el) Διαρυλ ενωσεις ως αναστολεις πρωτεασης σερινης
NZ333394A (en) Amidino derivatives and their use as thrombin inhibitors
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
CY1107149T1 (el) Νεα παραγωγα αμιδινοβενζυλαμινης και χρηση τους ως αναστολεων θρομβινης
PT1289972E (pt) Inibidores de serina proteases
MX9800146A (es) Nuevos inhibidores de trombina, su preparacion y su uso.
IS5511A (is) Ný efnasambönd
DE60105418D1 (de) Serinprotease-inhibitoren
SE0001803D0 (sv) New compounds i
TR200101651T2 (tr) Yeni amidino türevleri ve bunların trombin inhibitörü olarak kullanımı.
SE0102921D0 (sv) Pharmaceutically useful compounds
NO20030675D0 (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
MY133333A (en) New salts
IS7162A (is) Nýjar möndlusýruafleiður og notkun þeirra sem þrombínhemla
WO2004108892A3 (fr) $g(a)-aminoacides, $g(b)-aminoacides, diaminoalkyle contenant 1,1-disubstitue cycloalkyle, glycinamidyle, sulfonyl-amidino-, et tetrahydropyrimidinyle et leurs derives utilises comme inhibiteurs du facteur xa
TWI264434B (en) New mandelic acid derivatives and their use as thrombin inhibitors
TH36520A (th) อนุพันธ์อะมิดิโนชนิดใหม่และการใช้สารเหล่านั้นเป็นตัวยับยั้งธรอมบิน